Mergers and acquisitions – additional information
The world of business is always changing and dynamic. Companies merge together and acquire one another to form new companies. The benefit being an expansion of one’s client base, gaining access to further distribution channels and increasing technical knowledge among other factors. Further drivers include large cash reserves or commitments, opportunities in emerging markets and the availability of credit on favorable terms.
Apart from the technology industry, other industries with high-value merger and acquisition deals in the United States in 2022 include the industrials and chemicals industry, as well as the pharma, medical, and biotech industry. The latter experienced M&A deals exceeding a total value of 200 billion U.S. dollars. As of 2022, the largest deal in pharmaceutical industry history was Pfizer’s acquisition of Warner-Lambert for nearly 90 billion U.S. dollars in 2000. A further two deals in the rankings involve the American company Pfizer: its acquisitions of rival firms Pharmacia (2002) and Wyeth (2009). No M&A deal from the 2020s made it into the top list so far. The most recent big deals were the acquisitions of Allergan by AbbVie and of Celgene by Bristol-Myers Squibb, both in 2019.
A deal typically involves a lot of planning, strategy, money and risk, therefore a number of financial advisors are contracted to manage and advise each of the companies involved. Generally, the leading financial advisors for M&A deals are Goldman Sachs, JP Morgan Chase, and Morgan Stanley.